Journal of Advances in Biology & Biotechnology

TnpB proteins are among the most abundant genes encoded in bacterial and archaeal genomes, yet their function in the transposon life cycle remained unclear for decades. Recognition that TnpB is the likely evolutionary ancestor of type V CRISPR-Cas12 effector nucleases, followed by experimental demonstration that TnpB is itself a compact RNA-guided DNA endonuclease, has transformed these previously regarded accessory transposon proteins into a promising frontier in genome engineering. At roughly 350-410 amino acids, TnpB is less than half the size of Cas12a and approximately one-third the size of Cas9, making it well suited to delivery vehicles with constrained cargo capacity, such as adeno-associated virus (AAV). This review discusses recent progress in TnpB biology and technology. It first describes the biochemical and structural basis of RNA-guided DNA cleavage by TnpB and its role in transposon homing. It then summarises comparative genomic analyses that reveal the diversity of TnpB, repeated independent evolutionary transitions from TnpB to Cas12, and recurrent exaptation of TnpB for cellular functions unrelated to transposition. The review also considers how mining natural TnpB diversity and high-throughput protein engineering have produced compact editors with activity and specificity approaching established CRISPR-Cas tools in selected contexts, including early demonstrations of TnpB-mediated editing in animals and crop plants. It concludes by outlining the principal challenges, including transposon-associated motif (TAM) restriction, off-target activity, delivery and mechanistic understanding, that must be addressed before the therapeutic and agricultural potential of TnpB-derived technologies can be fully realised.